Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Tercica Raises $21.5M, Gains Rights To IGF-1 From Genentech

May 24, 2002

By Aaron Lorenzo

Genome Canada Supporting National Genomics Research

May 10, 2002

By Aaron Lorenzo

Genome Canada Supporting National Genomics Research

May 10, 2002

By Aaron Lorenzo

ISTA Acquires Rights To Three Ophthalmology Drug Candidates

May 7, 2002

By Aaron Lorenzo

ISTA Acquires Rights To Three Ophthalmology Drug Candidates

May 7, 2002

By Aaron Lorenzo

Panel Discusses Growing Role Of Pharmacogenomics

May 2, 2002

By Aaron Lorenzo

Panel Discusses Growing Role Of Pharmacogenomics

May 2, 2002

By Aaron Lorenzo

Applera Calls On Applied Bio To Distribute Celera System

April 23, 2002

By Aaron Lorenzo

Applera Calls On Applied Bio To Distribute Celera System

April 23, 2002

By Aaron Lorenzo

Organogenesis Conference Call Addresses Auditor’s Concerns

April 18, 2002

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...